Overview
Unipharm is an American pharmaceutical company specializing in products for the prevention and treatment of lifestyle diseases and in the development of nutraceuticals. It works with research and clinical centers and manufactures products to GMP standards, using ingredients from certified suppliers and conducting quality checks.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 62 days for 2019).
- 2025not filed
- 202429/07/2025
- 202327/06/2024
- 202213/09/2023
- 202126/07/2022
- 202004/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Industry
Offer
- Pharmaceutical preparations
- Nutraceuticals
- Preventive preparations
- Medicinal preparations
- Medical products
Website technology
- Website
- WordPress
Trademarks
Unipharm currently holds no active trademarks with the Polish Patent Office. 4 marks have expired or were not registered. The first mark was filed in 2003.
| Mark | Protected until | |
|---|---|---|
| Vitrum Lift-Skin Q10(word) | – | |
| Univit(word) | – | |
| UNIVIT JUNIOR(word) | – | |
| UNICAL 600(word) | – |
Authorized Representatives
Manner of representation
Each member of the management board is authorized to represent the company vis-à-vis third parties and administrative and judicial authorities, to make declarations concerning the company's rights and obligations, including to sign on behalf of the company, independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Unipharm Holdings Llc | 220 | $29,713.67 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2003-07-03.
59 1030 1016 0000 0000 3758 8008
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Goodwill Pharma Polskasp. z o.o. | $664,724.30 | goodwillpharma.com | ||
| PharmenaS.A. | $541,436.46 | pharmena.eu | ||
| Citipharm Spółka z Ograniczoną Odpowiedzialnoścąsp. z o.o. | $502,526.92 | citipharm.pl | ||
| Medis Polandsp. z o.o. | $487,846.47 | medis.com | ||
| Biocomsp. z o.o. | $433,929.05 | biocom.net.pl | ||
| Bonopharmsp. z o.o. | $405,123.74 | bonopharm.com | ||
| Effective Pharmsp. z o.o. | $246,062.91 | effectivepharm.pl | ||
| Vorwarts Pharmasp. z o.o. | $210,138.62 | vorwartspharma.pl | ||
| Powsenasp. z o.o. | $150,531.55 | powsena.pl | ||
| NutrisleP.S.A. | $135,614.44 | nutrisle.com |
Change history
| Date | Event | |
|---|---|---|
| 2023-08-23 | PKD change (Added: 47.29.Z, 47.91.Z) | |
| 2023-01-18 | Address change (Puławska 428, 02-884, Warszawa → Ul. Wiktorska 67/7, 02-582, Warszawa) | |
| 2018-01-18 | Switch to PKD 2007 (22 PKD 1997 codes → 7 PKD 2007 codes) | |
| 2003-11-27 | Share capital increase (50,000.00 PLN → 110,000.00 PLN) | |
| 2003-06-17 | Entered in the register |
FAQ
Last updated: 2026-10-07